NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-064-2016-1-US-08 PREFUSION RSV F PROTEINS AND THEIR USE US CON 17/524,380 11878998 Issued PDF
NCI E-044-2021-0-PCT-02 SMALL MOLECULE INHIBITORS OF STAT3 N-TERMINAL DOMAIN AND METHODS OF USE PCT PCT PCT/US2021/058936 Expired
NHLBI E-197-2020-0-PCT-02 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING PCT PCT PCT/US2021/058809 Expired
NICHD E-151-2021-0-US-01 Magnetic Resonance Method Of Measuring Water Exchange For Identifying Brain Physiology And Pathology US 63/277,881 Abandoned
NIA E-249-2016-0-US-19 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM US CON 17/522,687 11771657 Issued PDF
NHGRI E-034-2019-0-HK-16 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA HK EP 62021042143.9 Abandoned
NCI E-205-2021-0-US-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF US 63/277,287 Abandoned
NINR E-062-2022-0-PCT-03 Methods And Kits For Assessing Traumatic Brain Injury (TBI) Resulting From Blast Exposure PCT PCT PCT/US2021/072289 Expired
NIDDK E-011-2021-0-PCT-02 RNA SENSORS AND USES THEREOF PCT PCT PCT/IL2021/051318 Expired
NIDDK E-011-2021-0-US-02 RNA SENSORS AND USES THEREOF US National Stage 18/252,086 Pending
NINR E-062-2022-0-US-02 METHODS AND KITS FOR DETECTING TAU US ORD 17/453,991 Pending
NINR E-062-2022-0-EP-01 Methods And Kits For Assessing Traumatic Brain Injury (TBI) Resulting From Blast Exposure EP National Stage 21815867.3 Pending
NCI E-231-2020-0-PC-01 METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY PCT PCT PCT/EP2021/080796 Expired
NIAID E-060-2015-0-US-17 NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES US DIV 17/519,142 11938221 Issued PDF
NIAID E-064-2016-1-AU-09 SUBSTITUTIONS-MODIFIED PREFUSION RSV F PROTEINS AND THEIR USE AU DIV 2021261932 Issued
NCI E-060-2021-0-PCT-02 ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF PCT PCT PCT/US2021/058023 Expired
NCI E-064-2019-0-US-04 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 US National Stage 17/608,832 Pending
NCI E-060-2021-0-EP-01 ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF EP National Stage 21820745.4 Pending
NIBIB E-168-2021-0-US-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy US 63/275,736 Abandoned
NIAID E-095-2021-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 63/275,936 Abandoned
NIAID E-066-2020-1-KR-15 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING CROSS-DOUBLE VARIABLE DOMAIN (CODV) FORMS FOR THE TREATMENT OF HIV INFECTION KR National Stage 10-2021-7036095 Abandoned
NIAID E-081-2013-4-RU-20 Prefusion RSV F Proteins And Their Use RU DIV 2021132097 Issued
NHLBI E-085-2019-0-CN-02 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE CN National Stage 202080033275.9 Issued
NHLBI E-005-2021-0-PCT-02 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE PCT PCT PCT/US2021/057845 Expired
NIAID E-066-2020-1-NZ-13 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING THE CROSS-OVER-DUAL VARIABLE DOMAIN (CODV) FORMAT FOR TREATMENT OF HIV INFECTION NZ National Stage 782001 Abandoned
NIAID E-087-2019-0-US-03 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US National Stage 17/608,381 12269872 Issued PDF
NIAID E-106-2016-0-US-05 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE US CON 17/517,597 11938177 Issued PDF
NHLBI E-322-2007-0-US-02 Nucleosides Protect Against Irradiation And Other Stresses US DIV 17/517,148 Abandoned
NCI E-150-2020-0-PCT-02 Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome PCT PCT PCT/US2021/057229 Expired
NCI E-015-2022-0-US-01 Cell Modification Device And Method For Automating Preparation of Personalized Tumor Vaccine US 63/273,819 Abandoned
NICHD E-200-2021-0-US-01 Use of Carboxypeptidase E / Neurotrophic Factor-Alpha 1 to Treat Neurodegenerative Disease US 63/273,312 Abandoned
NCI E-028-2015-1-CN-41 Anti-Mutated Kras T Cell Receptors CN DIV 202111263859.8 Issued
NCI E-021-2015-0-CN-34 Anti-CD70 Chimeric Antigen Receptors CN DIV 202111253336.5 Pending
NCI E-253-2020-0-PCT-02 SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF PCT PCT PCT/US2021/056548 Expired
NCI E-240-2015-1-CN-09 Methods of Analyzing Virus-Derived Therapeutics CN DIV 202111246733X Abandoned
NCI E-204-2021-0-US-01 Single Domain Antibodies Targeting The S2 Subunit Of SARS-CoV-2 Spike Protein US 63/271,854 Abandoned
NCI E-132-2012-0-US-12 ALTERING THE IMMUNDOMINANCE HIERARCHY USING A DNA VACCINE EXPRESSING CONSERVED REGIONS US CON 17/511,499 Abandoned
NIAID E-052-2017-4-NZ-86 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection NZ DIV 781602 Abandoned
NCATS E-060-2019-0-US-03 NOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS US National Stage 17/605,876 Pending
NEI E-162-2016-0-JP-32 GENE THERAPY FOR RETINITIS PIGMENTOSA JP DIV 2021-172128 Issued
NIAID E-220-2020-0-PCT-02 ANTIBODIES THAT NEUTRALIZE TYPE-I INTERFERON (IFN) ACTIVITY PCT PCT PCT/US2021/056067 Expired
NIAID E-133-2015-0-EP-10 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE EP DIV 21204045.5 Pending
NINDS E-102-2019-1-EP-04 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS EP National Stage 20726999.4 Issued
NINDS E-102-2019-1-GB-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS GB EP 20726999.4 Issued
NINDS E-102-2019-1-NL-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS NL EP 20726999.4 Issued
NINDS E-102-2019-1-DE-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS DE EP 20726999.4 Issued
NINDS E-102-2019-1-FR-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS FR EP 20726999.4 Issued
NCATS E-060-2019-0-CA-04 A Highly Efficient Nociceptor Differentiation Protocol For Human Pluripotent Stem Cells CA National Stage 3137838 Pending
OD E-120-2021-0-US-01 PREDICTION OF TRANSFORMATIVE BREAKTHROUGHS IN RESEARCH US 63/257,818 Abandoned
NCI E-192-2023-0-US-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis US 63/262,788 Expired